Even as drug pricing issues continue to draw scrutiny, federal safety regulations and incentives offer drug companies a new avenue to get a sweet return on their development costs.
Researchers concluded that because the federal government picked up so much of the tab of expanding eligibility for the low-income insurance program, expansion states like California didn’t have to skimp on other policy priorities to make ends meet.
Research published today suggests childhood lead exposure, which affects half a million children and which the CDC has been deemed a major public concern, doesn’t just impact cognitive development but also undermines class mobility.
Un nuevo estudio comprueba que el envenenamiento por plomo en la niñez sigue afectando durante la vida adulta, no solo la salud sino también el ascenso social.
A provision in the 2010 health law required these hospitals to justify their tax exemption by demonstrating involvement in community health. Repeal, replace or repair could stall that momentum.
Epinephrine, the active ingredient in EpiPens, expires after 18 months, and the auto-injector device can’t be refilled or reused. Health professionals are looking for work-arounds they say could save the health system millions.
Aetna will be the third major insurer to remove prior authorization requirements for patients who seek medication-assisted treatments such as Suboxone.
In an interview with Kaiser Health News, Michael Botticelli outlined his concerns about how GOP efforts to dismantle the health law’s coverage expansions could jeopardize treatment for people in need.
The device, known as an Evzio, administers just enough naloxone to stabilize someone who has overdosed on drugs. But its manufacturer, Kaleo, may be positioning itself to find profits in a dire health care crisis.
Republican plans to transform Medicaid could help set debate on the role of government and entitlements. Here’s an explanation of how it could work.